Journal Article

Resolution of Chronic Parvovirus B19-Induced Anemia, by Use of Highly Active Antiretroviral Therapy, in a Patient with Acquired Immunodeficiency Syndrome

Athol J. Ware and Theresa Moore

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 32, issue 7, pages e122-e123
Published in print April 2001 | ISSN: 1058-4838
Published online April 2001 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/319590
Resolution of Chronic Parvovirus B19-Induced Anemia, by Use of Highly Active Antiretroviral Therapy, in a Patient with Acquired Immunodeficiency Syndrome

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

We present what is, to our knowledge, the second case report of a patient with acquired immunodeficiency syndrome and transfusion-dependent anemia caused by persistent infection with parvovirus B19. The patient's anemia was successfully treated, and she demonstrated serologic evidence of eradication of parvovirus after having received effective therapy for human immunodeficiency virus infection.

Journal Article.  1141 words. 

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.